Prior to joining ABio-X, Siyuan led business development at VISEN Pharmaceutical. During her tenure at VISEN, she built the strategic framework to enrich the company pipeline through BD&L and spearheaded the $150 million Series B fundraising. Earlier in her career, Siyuan worked as an investment professional at healthcare-focused venture funds. Siyuan earned her Bachelor of Science and PhD from Fudan University. During her academic years, she published six peer-reviewed papers as the first author and filed one patent.